Concepts represent early planning stages for program announcements, requests for applications, notices of special interest, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.
Note: Council approval does not guarantee that a concept will become an initiative.
Table of Contents
Fiscal Year (FY) 2024 Concepts
- Bioinformatics Resource Centers (BRCs) for Infectious Diseases
- Animal Models for Hepatitis B and C
- Collaborative Partnership to Advance Global Health Research
- International Research in Infectious Diseases
- Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae, and Picornaviridae
- Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae
- Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network - Coordination and Data Sharing Center (CDSC)
- Notice of Special Interest (NOSI)—Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics
- Notice of Special Interest (NOSI)—Advancing Research for Tickborne Diseases (TBDs)
- Notice of Special Interest (NOSI)—Targeting the Pathogen Within the Arthropod Vector
FY 2024 Small Business Innovation Research (SBIR) Contract Solicitation Topics
- Alternatives to Benzathine Penicillin for Treatment of Syphilis
- Development of Bacteriophage for Treatment of Mycobacterial Infections
- Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections
- Novel Diagnostic Biomarker Discovery and Validation for Malaria and Select Neglected Tropical Diseases (NTDs)
Bioinformatics Resource Centers (BRCs) for Infectious Diseases
For the published request for applications, check the May 15, 2023 Guide notice, Bioinformatics Resource Centers (BRCs) for Infectious Diseases (U24 Clinical Trials Not Allowed).
Animal Models for Hepatitis B and C
For the published request for applications, check the March 28, 2023, Guide announcement, Animal Models for Hepatitis B and C (R01 Clinical Trial Not Allowed).
Collaborative Partnership to Advance Global Health Research
Program Announcement with Special Receipt, Referral, and/or Review Considerations—proposed FY 2024 initiative
Contact:
Stephanie Coomes
stephanie.coomes@nih.gov
Objective: To develop, establish, implement, and maintain a successful collaborative partnership to advance NIAID priorities, support NIH collaboration on global health, and advance health research internationally.
Description: This initiative would support the development, implementation, establishment, and maintenance of a collaborative partnership to advance health research internationally. Specifically, this funding opportunity announcement seeks to:
- Support and strengthen international basic, applied, and clinical biomedical research activities to better acquire fundamental scientific knowledge and to apply and advance that knowledge to enhance health.
- Develop, maintain, and enhance research-related education and advanced training to increase research capability to study the causes, improve diagnosis, implement better prevention methodologies, and seek treatments and cures of human diseases.
- Develop, maintain, and enhance research-related resources to increase research capability worldwide.
- Disseminate scientific knowledge to facilitate global utilization of research findings and the coordination of evidence-based improvements in health.
- Assess and evaluate health-related programs focused on health research and public health.
International Research in Infectious Diseases
For the published request for applications, check the April 14, 2023 Guide announcement, International Research in Infectious Diseases (R01, Clinical Trial Not Allowed).
Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae, and Picornaviridae
For the published request for applications, check the March 16, 2023 Guide announcement, Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical Trial Not Allowed).
Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae
For the published request for applications, check the March 16, 2023 Guide announcement, Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae (U19 Clinical Trial Not Allowed).
Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network - Coordination and Data Sharing Center (CDSC)
For the published request for applications, check the March 16, 2023 Guide announcement, Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network – Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed).
Notice of Special Interest (NOSI)—Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics
For the published notice of special interest, check the November 25, 2022 Guide notice, Notice of Special Interest (NOSI)—Advancing Development of Rapid Point-of-Care Hepatitis C Virus Diagnostics.
Notice of Special Interest (NOSI)—Advancing Research for Tickborne Diseases (TBDs)
For the published notice of special interest, check the November 25, 2022 Guide notice, Notice of Special Interest (NOSI)—Advancing Research for Tickborne Diseases (TBDs).
Notice of Special Interest (NOSI)—Targeting the Pathogen Within the Arthropod Vector
For the published notice of special interest, check the October 3, 2022 Guide notice, Notice of Special Interest (NOSI)—Targeting the Pathogen Within the Arthropod Vector.
Alternatives to Benzathine Penicillin for Treatment of Syphilis
Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2024-1.
Request for Proposals
Contact:
Charles H. Jackson, Jr.
charles.jackson@nih.gov
Development of Bacteriophage for Treatment of Mycobacterial Infections
Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2024-1.
Request for Proposals
Contact:
Charles H. Jackson, Jr.
charles.jackson@nih.gov
Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections
Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2024-1.
Request for Proposals
Contact:
Charles H. Jackson, Jr.
charles.jackson@nih.gov
Novel Diagnostic Biomarker Discovery and Validation for Malaria and Select Neglected Tropical Diseases (NTDs)
Note: NIAID topic proposed for NIH SBIR contract solicitation PHS 2024-1.
Request for Proposals
Contact:
Charles H. Jackson, Jr.
charles.jackson@nih.gov